These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 15525722)

  • 1. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
    N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity.
    Clark LN; Nicolai A; Afridi S; Harris J; Mejia-Santana H; Strug L; Cote LJ; Louis ED; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Mayeux R; Ottman R; Marder K
    Mov Disord; 2005 Jan; 20(1):100-3. PubMed ID: 15517591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
    De Marco EV; Annesi G; Tarantino P; Rocca FE; Provenzano G; Civitelli D; Cirò Candiano IC; Annesi F; Carrideo S; Condino F; Nicoletti G; Messina D; Novellino F; Morelli M; Quattrone A
    Mov Disord; 2008 Feb; 23(3):460-3. PubMed ID: 18074383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.
    Toft M; Pielsticker L; Ross OA; Aasly JO; Farrer MJ
    Neurology; 2006 Feb; 66(3):415-7. PubMed ID: 16476943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E
    Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
    Sidransky E; Nalls MA; Aasly JO; Aharon-Peretz J; Annesi G; Barbosa ER; Bar-Shira A; Berg D; Bras J; Brice A; Chen CM; Clark LN; Condroyer C; De Marco EV; Dürr A; Eblan MJ; Fahn S; Farrer MJ; Fung HC; Gan-Or Z; Gasser T; Gershoni-Baruch R; Giladi N; Griffith A; Gurevich T; Januario C; Kropp P; Lang AE; Lee-Chen GJ; Lesage S; Marder K; Mata IF; Mirelman A; Mitsui J; Mizuta I; Nicoletti G; Oliveira C; Ottman R; Orr-Urtreger A; Pereira LV; Quattrone A; Rogaeva E; Rolfs A; Rosenbaum H; Rozenberg R; Samii A; Samaddar T; Schulte C; Sharma M; Singleton A; Spitz M; Tan EK; Tayebi N; Toda T; Troiano AR; Tsuji S; Wittstock M; Wolfsberg TG; Wu YR; Zabetian CP; Zhao Y; Ziegler SG
    N Engl J Med; 2009 Oct; 361(17):1651-61. PubMed ID: 19846850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Eblan MJ; Walker JM; Sidransky E
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15716572
    [No Abstract]   [Full Text] [Related]  

  • 11. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Zimran A; Neudorfer O; Elstein D
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719452
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the glucocerebrosidase gene in Parkinson's disease.
    Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E
    Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
    Aharon-Peretz J; Badarny S; Rosenbaum H; Gershoni-Baruch R
    Neurology; 2005 Nov; 65(9):1460-1. PubMed ID: 16148263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage disequilibrium of common Gaucher disease mutations with a polymorphic site in the pyruvate kinase (PKLR) gene.
    Rockah R; Narinsky R; Frydman M; Cohen IJ; Zaizov R; Weizman A; Frisch A
    Am J Med Genet; 1998 Jul; 78(3):233-6. PubMed ID: 9677056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.
    Ran C; Brodin L; Forsgren L; Westerlund M; Ramezani M; Gellhaar S; Xiang F; Fardell C; Nissbrandt H; Söderkvist P; Puschmann A; Ygland E; Olson L; Willows T; Johansson A; Sydow O; Wirdefeldt K; Galter D; Svenningsson P; Belin AC
    Neurobiol Aging; 2016 Sep; 45():212.e5-212.e11. PubMed ID: 27255555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-morbidity in Gaucher's disease results of a nationwide enquiry in Spain.
    Pérez-Calvo J; Bernal M; Giraldo P; Torralba MA; Civeira F; Giralt M; Pocovi M
    Eur J Med Res; 2000 Jun; 5(6):231-5. PubMed ID: 10882637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
    Schmid SP; Schleicher ED; Cegan A; Deuschle C; Baur S; Hauser AK; Synofzik M; Srulijes K; Brockmann K; Berg D; Maetzler W
    Mov Disord; 2012 Feb; 27(2):288-92. PubMed ID: 22021190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.